Addition of sunitinib to biweekly cetuximab and irinotecan (CetIri) as salvage therapy in patients with advanced colorectal cancer after failure to CetIri

Camilla Qvortrup, Benny Vittrup Jensen, Trine Lembrecht Jørgensen, D Nielsen, Jon Kroll Bjerregaard, Per Pfeiffer

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalActa Oncologica
Pages (from-to)833-6
Publication statusPublished - 2010

Cite this